alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT B 

Case 2:23-cv-00123-JRG-RSP Document 104-2 Filed 04/19/24 Page 1 of 2 PageID

#: 1634
December 13, 2023 

Page 2 of 6 

4. All Documents, Communications, and Things that refer or relate to Daingean Technologies 

Limited, the Patents-in-Suit, or this lawsuit; 

5. All Documents, Communications, and Things identifying and detailing the 5G-capable or 

5G-aware base stations deployed within AT&T’s networks (“Accused Products”); 

6. All Documents, Communications, and Things detailing testing of the Accused Products; 

7. All Documents, Communications, and Things identifying and detailing the software 

deployments (past and present versions) for the Accused Products; 

8. All Documents, Communications, and Things detailing the design, development, and 

testing of the software deployments (past and present versions) for the Accused Products; 

9. All Documents, Communications, and Things identifying and detailing the licensed 

features enabled on the Accused Products and the times during which those features have been 

enabled; 

10. All Documents, Communications, and Things detailing the benefits derived from the 

licensed features enabled on the Accused Products; 

11. All Documents, Communications, and Things detailing AT&T’s investment in 

procurement, deployment, configuration, operation, and maintenance of the Accused Products; 

12. All Documents, Communications, and Things that constitute, refer to, or relate to 

marketing the Accused Products or services enabled by the Accused Products; 

13. All Documents, Communications, and Things that You contend evidence the level of 

ordinary skill in the art pertaining to the inventions claimed in the Patents-in-Suit; 

14. All Documents, Communications, and Things that evidence, contradict, refer to, or relate 

to any secondary considerations of non-obviousness concerning the Patents-in-Suit; 

15. All Documents, Communications, and Things relating to any request for indemnification 

You have made relating to this lawsuit; 

16. All Documents, Communications, and Things relating to Your patent clearance or patent 

avoidance policies; 

17. All Documents, Communications, and Things relating to any advantage or improvement 

provided by the inventions claimed in the Patent-in-Suit; 

18. All Documents, Communications, and Things that constitute, refer to, or relate to the 

appropriate measure of damages to compensate Daingean for Your infringement of any of the 

Patents-in-Suit; 

19. All Documents, Communications, and Things that constitute, refer to, or relate to the value 

or valuation of the Patents-in-Suit or any inventions of the Patents-in-Suit; 

Case 2:23-cv-00123-JRG-RSP Document 104-2 Filed 04/19/24 Page 2 of 2 PageID

#: 1635
Valentino JACKSON, petitioner, v. GEORGIA.

No. 17-8842.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Supreme Court of Georgia denied.
**Exhibit 32.1**

 

**AFFINITYGROUP, INC.**

 

**STATEMENTPURSUANT TO 18 U.S.C. SECTION 1350**

 

I, Michael A. Schneider, President and ChiefExecutive Officer of Affinity Group, Inc., a Delaware corporation (the “Company”),hereby certify as follows:

 

1.                                       Thisstatement is provided pursuant to 18 U.S.C. Section 1350 in connection with theCompany’s Quarterly Report on Form 10-Q for the quarterly period ended September30, 2004 (the “Periodic Report”);

 

2.                                       ThePeriodic Report fully complies with the requirements of section 13(a) and 15(d)of the Securities Exchange Act of 1934, as amended; and

 

3.                                       Theinformation contained in the Periodic Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company asof dates and for the periods indicated therein.

 

 
| Date:  November 8, 2004 |                                   |
|-------------------------|----------------------------------------|
|                    |                                   |
|                    | /s/  Michael A.Schneider               |   |
|                    | Michael  A. Schneider                  |
|                    | President  and Chief Executive Officer |

 

 

Asigned original of this written statement required by Section 906, or suchother document authenticating, acknowledging, or otherwise adopting thesignature that appears in typed form within the electronic version of thewritten statement as required by Section 906, has been provided to AffinityGroup, Inc. and will be retained by Affinity Group, Inc. and furnished to theSecurities and Exchange Commission or its staff upon request.

 

----
Glover A. YAWN, Jr., petitioner, v. UNITED STATES.

No. 18-6277.

Supreme Court of the United States

Nov. 5, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

# FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT:

87 FR 27669, May 9, 2022.

# PREVIOUSLY ANNOUNCED TIME AND DATE OF THE MEETING:

 Thursday, May 12, 2022 at 2 p.m.

# CHANGES IN THE MEETING:

 The Closed Meeting scheduled for Thursday, May 12, 2022 at 2:00 p.m., has been cancelled.

# CONTACT PERSON FOR MORE INFORMATION:

 For further information; please contact Vanessa A. Countryman from the Office of the Secretary at (202) 551-5400.

(Authority: 5 U.S.C. 552b.)

Dated: May 12, 2022.

Eduardo A. Aleman,

Deputy Secretary.

[FR Doc. 2022-10569 Filed 5-12-22; 4:15 pm]

BILLING CODE 8011-01-P
Willie TRIPLETT, Jr., petitioner, v. Darrel VANNOY, Warden.

No. 18-6055.

Supreme Court of the United States

Nov. 19, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET OF THE MAXIM GROUP, INC. AND SUBSIDIARIES AS OF
OCTOBER 31, 1998 AND THE RELATED CONSOLIDATED STATEMENTS OF INCOME AND CASH
FLOWS FOR THE PERIOD ENDED OCTOBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JAN-31-1999
<PERIOD-START>                             FEB-01-1998
<PERIOD-END>                               OCT-31-1998
<CASH>                                          34,152
<SECURITIES>                                         0
<RECEIVABLES>                                  117,161
<ALLOWANCES>                                     4,978
<INVENTORY>                                    112,450
<CURRENT-ASSETS>                               273,505
<PP&E>                                         247,161
<DEPRECIATION>                                  58,715
<TOTAL-ASSETS>                                 536,095
<CURRENT-LIABILITIES>                          239,222
<BONDS>                                        116,041
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            21
<OTHER-SE>                                     170,754
<TOTAL-LIABILITY-AND-EQUITY>                   536,095
<SALES>                                        464,125
<TOTAL-REVENUES>                               464,125
<CGS>                                          308,907
<TOTAL-COSTS>                                  123,510
<OTHER-EXPENSES>                                   307
<LOSS-PROVISION>                                   850
<INTEREST-EXPENSE>                               8,917
<INCOME-PRETAX>                                 (9,139)
<INCOME-TAX>                                    (1,299)
<INCOME-CONTINUING>                             (7,840)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                    377
<CHANGES>                                            0
<NET-INCOME>                                    (8,217)
<EPS-PRIMARY>                                     (.47)
<EPS-DILUTED>                                     (.47)
        

</TABLE>
Deshawn T. TERRELL, petitioner, v. OHIO.

No. 18-5239.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Court of Appeals of Ohio, Cuyahoga County denied.
Dexter WATSON, petitioner, v. Raymond BYRD, Warden.

No. 18-6497.

Supreme Court of the United States

Dec. 3, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
[Federal Register Volume 87, Number 100 (Tuesday, May 24, 2022)]
[Notices]
[Page 31585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-11085]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF MANAGEMENT AND BUDGET


Discount Rates for Cost-Effectiveness Analysis of Federal 
Programs

AGENCY: Office of Management and Budget.

ACTION: Revisions to Appendix C of OMB Circular A-94.

-----------------------------------------------------------------------

SUMMARY: The Office of Management and Budget (OMB) revised Circular A-
94 in 1992. With that action, OMB specified certain discount rates to 
be updated annually when the interest rate and inflation assumptions 
used to prepare the Budget of the United States Government were 
changed. These updated discount rates are found in Appendix C of the 
revised Circular and are to be used for cost-effectiveness analysis, 
including lease-purchase analysis, as specified in the revised 
Circular. These rates do not apply to regulatory analysis.
    The revised Circular can be accessed at https://www.whitehouse.gov/wp-content/uploads/2022/05/Appendix-C.pdf.

DATES: The revised discount rates will be in effect through December 
2022.

FOR FURTHER INFORMATION CONTACT: Rachel Hern[aacute]ndez, Office of 
Economic Policy, Office of Management and Budget, (202) 395-3585.

Danny Yagan,
Associate Director for Economic Policy, Office of Management and 
Budget.
[FR Doc. 2022-11085 Filed 5-23-22; 8:45 am]
BILLING CODE 3110-01-P
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

ARTHUR MCCORKLE,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 554 MAL 2021

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 31st day of March, 2022, the Petition for Allowance of Appeal is 

DENIED.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Swift Energy
Pension Partners 1993-A, Ltd.'s balance sheet and statement of operations con-
tained in its Form 10-Q for the quarter ended June 30, 1997 and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-END>                                   JUN-30-1997
<CASH>                                         1,033
<SECURITIES>                                   0
<RECEIVABLES>                                  110,487
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               111,520
<PP&E>                                         4,117,466
<DEPRECIATION>                                 (1,873,582)
<TOTAL-ASSETS>                                 2,355,404
<CURRENT-LIABILITIES>                          5,044
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     2,350,360
<TOTAL-LIABILITY-AND-EQUITY>                   2,355,404
<SALES>                                        327,082
<TOTAL-REVENUES>                               327,115
<CGS>                                          0
<TOTAL-COSTS>                                  159,379<F1>
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                132,003
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            132,003
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   132,003
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
<FN>
<F1>Includes lease operating expenses, production taxes and depreciation,
depletion and amortization expense.  Excludes general and administrative and
interest expense.
</FN>
        


</TABLE>
```
  
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 07/24/12          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      324,056
COMMITMENTS
  69,718  138,194   51,355  177,352  110,386  298,425  299,935   25,631   24,121

CHANGES FROM 07/17/12 (CHANGE IN OPEN INTEREST:    -26,712)
  -2,512    4,912     -555  -23,899  -30,208  -26,966  -25,851      254     -861

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    21.5     42.6     15.8     54.7     34.1     92.1     92.6      7.9      7.4

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      138)
      39       61       58       27       30      105      116
```

----

Updated July 27, 2012
Exhibit 10.2




AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT




This Amendment No. 1 dated as of March 15, 2019 (this “Amendment”) to the Third Amended and Restated Employment Agreement (the “Agreement”), effective as of November 1, 2017, by and between Genie Energy Ltd., a Delaware corporation (the “Company”), and Howard S. Jonas (the “Executive”), modifies the terms of the Agreement as set forth herein. 

WITNESSETH 

WHEREAS, Company and Executive desire to modify the terms and conditions of the Agreement on the terms set forth herein.

NOW THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto agree as follows: 

1. Section 6(b)(i) of the Agreement is replaced in its entirety with the following:

In addition, from and after March 15, 2019 through the end of the Base Term, Executive’s  cash base salary shall be ONE HUNDRED THOUSAND DOLLARS ($100,000) per annum, payable in accordance with the Company’s standard payroll practices, less applicable taxes and customary withholdings.

All other terms and conditions of the Agreement remain unchanged by this Amendment.




[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 





	1












IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the day and year first above written. 


    


	
 


	
GENIE ENERGY LTD. 


	

	

	
/s/ Michael Stein


	
Name:  Michael Stein


	
Title: Chief Executive Officer


	
 


	
 


	
/s/ Howard S. Jonas


	
Howard S. Jonas

 










	2
Gary Allen KACHINA, petitioner, v. UNITED STATES.

No. 18-5456.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
atnx-ex1045_921.htm



Exhibit 10.45

FIFTH AMENDMENT TO LICENSE AGREEMENT

THIS FIFTH AMENDMENT TO LICENSE AGREEMENT (this “Fifth Amendment”) is made and entered as of September 4, 2018 (“Effective Date”), by and between ATHENEX INC., (formerly known as Kinex Pharmaceuticals INC. and prior, Kinex Pharmaceuticals, LLC.), a publicly traded corporation organized and existing under the laws of the State of Delaware, and having its principal office in Suite 600, Conventus Building, 1001 Main Street, Buffalo, New York 14203, United States (“Athenex”) and HANMI PHARMACEUTICAL CO., LTD., a publicly traded company existing under the laws of South Korea and having its principal office at 14, Wiryeseong-daero, Songpa-gu, Seoul, 05545, South Korea (“Hanmi”).

WITNESSTH:

WHEREAS, Hanmi and Athenex (under the name of its predecessor entity, Kinex Pharmaceuticals, LLC) entered into a license agreement on December 16, 2011 for the license by Hanmi to Athenex of rights in the Hanmi Orascovery Program (“License Agreement”), which License Agreement was previously amended by First Amendment to License Agreement on November 9, 2012, Second Amendment to License Agreement on October 21, 2013, Third Amendment to the License Agreement dated March 3, 2015 and Fourth Amendment to License Agreement on March 7, 2017 (the “License”); and

WHEREAS, Hanmi and Athenex now wish to amend the License to amend the definition of “Territory” to add all the remaining Global Territories not covered by this Agreement and its amendments including Middle East and North Africa region (“MENA”) and South Africa but explicitly excluding the Korea Territory which remains to be the Territory for Hanmi.

NOW, THEREFORE, the Parties hereby agree as follows:


	
 
	
1.
	
All capitalized terms used in this Fifth Amendment and not defined herein shall have the meaning given to them in the License. Except as amended by this Fifth Amendment, the License shall continue in full force and effect.





	
 
	
2.
	
Section 1.66 of the License is amended and restated in its entirety to read as follows: “Territory” means all countries in the world excluding Korea.
	
 





	
 
	
3.
	
In consideration for this Fifth Amendment, Athenex shall pay to Hanmi USD $40,000 within 45 days of the Effective Date of this Fifth Amendment.




IN WITNESS WHEREOF, the Parties have executed this Fifth Amendment as of the date first set forth above.

 


	
ATHENEX, INC.
	
 
	
HANMI PHARMACEUTICAL CO., LTD.

	
 
	
 
	
 
	
 
	
 

	
By:
	
/s/ Johnson Lau
	
 
	
By:
	
/s/ Se Chang Kwon

	
Johnson Lau

Chief Executive Officer
	
 
	
Se Chang Kwon

Chief Executive Officer
Jose Manuel LOPEZ, petitioner, v. CITY OF SANTA ANA, CALIFORNIA, et al.

No. 17-8609.

Supreme Court of the United States

Aug. 24, 2018.

Petition for rehearing denied.
<TABLE> <S> <C>

<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                       7,591,117
<INT-BEARING-DEPOSITS>                       6,361,293
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                117,289,086
<INVESTMENTS-CARRYING>                       6,919,793
<INVESTMENTS-MARKET>                         6,627,235
<LOANS>                                    323,724,213
<ALLOWANCE>                                  2,706,408
<TOTAL-ASSETS>                             492,326,958
<DEPOSITS>                                 345,341,089
<SHORT-TERM>                                 1,305,873
<LIABILITIES-OTHER>                          6,621,072
<LONG-TERM>                                 98,197,737
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        49,241
<OTHER-SE>                                  40,811,946
<TOTAL-LIABILITIES-AND-EQUITY>             492,326,958
<INTEREST-LOAN>                             22,758,455
<INTEREST-INVEST>                            9,405,583
<INTEREST-OTHER>                               721,798
<INTEREST-TOTAL>                            32,885,836
<INTEREST-DEPOSIT>                          14,755,940
<INTEREST-EXPENSE>                          19,909,013
<INTEREST-INCOME-NET>                       12,976,823
<LOAN-LOSSES>                                  205,837
<SECURITIES-GAINS>                             229,708
<EXPENSE-OTHER>                             10,902,767
<INCOME-PRETAX>                              4,804,996
<INCOME-PRE-EXTRAORDINARY>                   2,859,885
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,859,885
<EPS-BASIC>                                     0.72
<EPS-DILUTED>                                     0.70
<YIELD-ACTUAL>                                    7.38
<LOANS-NON>                                    818,000
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                              1,166,000
<ALLOWANCE-OPEN>                             1,973,410
<CHARGE-OFFS>                                  506,753
<RECOVERIES>                                   179,751
<ALLOWANCE-CLOSE>                            2,706,408
<ALLOWANCE-DOMESTIC>                           259,274
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                      2,447,134


</TABLE>